Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06315179 · ClinicalTrials.gov registry record
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
A clinical trial of Ulcerative Colitis and Crohn Disease, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06315179 is a study of Ulcerative Colitis and Crohn Disease that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 200 participants, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06315179, a study of Ulcerative Colitis and Crohn Disease, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Esophagogastroduodenoscopy (EGD) with biopsy
- DIAGNOSTIC_TEST Colonoscopy w/ biopsy
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06315179
The ClinicalTrials.gov registry entry for NCT06315179 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (90% lower). The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which Esophagogastroduodenoscopy (EGD) with biopsy is the first listed.
NCT06315179 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06315179 about?
NCT06315179 is a clinical study titled "Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)". This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inf...
What is the current status of trial NCT06315179?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-05-10. Estimated completion is 2030-01.
What conditions does trial NCT06315179 study?
This clinical trial studies the following conditions: Ulcerative Colitis, Crohn Disease, Inflammatory Bowel Diseases, Indeterminate Colitis, Esophageal Diseases.
What interventions are being tested in trial NCT06315179?
The interventions under investigation include: Esophagogastroduodenoscopy (EGD) with biopsy (DIAGNOSTIC_TEST), Colonoscopy w/ biopsy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06315179?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06315179 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.